Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Daiichi Sankyo UK Limited
Chiltern Place, Chalfont Park, Gerrards Cross, Buckinghamshire, SL9 0BG, UK
Telephone: +44 (0)1753 482 771
Medical Information Direct Line: +44 (0)1753 482 771
Medical Information e-mail: medinfo@daiichi-sankyo.co.uk
Customer Care direct line: +44 (0)1753 482 771
Medical Information Fax: +44 (0)1753 893 894
Out of Hours Telephone: +44 (0)1748 828 818

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 13/02/2012
PIL OLMETEC Plus film-coated tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 13/02/2012 and displayed until Current
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to drug interactions
Updated on 12/10/2011 and displayed until 13/02/2012
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
Updated on 29/10/2010 and displayed until 12/10/2011
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 05/05/2010 and displayed until 29/10/2010
Reasons for adding or updating:
  • Addition of information on alternative format leaflets
Updated on 09/12/2009 and displayed until 05/05/2010
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to side-effects
  • Change to information about pregnancy or lactation
Updated on 14/10/2009 and displayed until 09/12/2009
Reasons for adding or updating:
  • Individual presentations superseded by joint PIL
  • Change due to user-testing of patient information
Updated on 26/09/2006 and displayed until 14/10/2009
Reasons for adding or updating:
  • Company name change or merger
Updated on 27/04/2006 and displayed until 26/09/2006
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 26/04/2006 and displayed until 27/04/2006
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
  hydrochlorothiazide
  olmesartan medoxomil